Berkshire-based medical device manufacturer Occuity has secured £2.85m of investment to develop a new device that would allow people with diabetes to monitor their blood sugar levels via an eye scan.
Occuity’s original funding goal of £1.8m was reached within 24 hours of launch on crowdfunding website Seedrs.
The Occuity Indigo was described as a non-contact, optical glucose meter and fits into the hand easily. It could also be used to screen for diabetes in just a few seconds, according to the company.
CEO and co-founder, Dr Dan Daly said: ‘Diabetes is a growing, global problem and we believe our technology will enable health services throughout the world to monitor and screen for diabetes, improving the clinical outcomes for hundreds of millions of people who are unaware they have pre-diabetes or diabetes.’
Register now to continue reading
Thank you for visiting Optician Online. Register now to access up to 10 news and opinion articles a month.
Register
Already have an account? Sign in here